---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-046980"
form_type: "8-K"
ticker: "CGTX"
cik: "0001455365"
company_name: "COGNITION THERAPEUTICS INC"
filed_at: "2023-04-19T23:59:59+00:00"
generated_at: "2026-06-16T23:32:32.866443+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.05
calibrated_materiality_score: 0.05
confidence: "low"
source: SEC EDGAR
---

# Cognition Therapeutics files investor presentation; no specific financial or clinical data disclosed.

## Summary
- Filing under Item 7.01 attaches a presentation for an analyst breakfast meeting in April 2023.
- Presentation exhibit contains only a title slide; no pipeline, financial, or clinical updates are provided.
- No earnings, guidance, or material operational changes are reported in the filing.
- Cognition Therapeutics is a clinical-stage company focused on disease-modifying medicines for degenerative disorders.

## SEC filing metadata
- accession: 0001104659-23-046980
- form_type: 8-K
- ticker: CGTX
- cik: 0001455365
- company_name: COGNITION THERAPEUTICS INC
- filed_at: 2023-04-19T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.05
- calibrated_materiality_score: 0.05
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1455365/000110465923046980/0001104659-23-046980-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1455365/000110465923046980/tm2313109d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-046980
- JSON: https://secwatch.observer/filing/0001104659-23-046980.json
- Plain text: https://secwatch.observer/filing/0001104659-23-046980.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.